OHAM Research
OHAM facilitates HIV and AIDS malignancy research by coordinating and overseeing research programs throughout the NCI, as well as directly initiating and managing programs. Together, these major programs and initiatives in research, training, international studies, and clinical trials are driving important advances towards more effective prevention, diagnosis, and treatment of HIV/AIDS and HIV-associated malignancies within the United States and abroad.
 |
Photomicrograph of an HIV-associated large cell lymphoma with CD68 stained in blue and proliferating cell nuclear antigen (PCNA) stained in brown. |
A number of research activities are directly managed by OHAM:
Main Research Programs- AIDS Malignancy Consortium
- AIDS and Cancer Specimen Resource
- Strengthening Capacity for Research for HIV-Associated Malignancies in Africa
- International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies
In addition, OHAM contributes to and has shared oversight for a number of training, research, and clinical trial efforts across the NIH and beyond:
Trans-NIH and Other Collaborative Activities
The burden of HIV/AIDS and HIV malignancies is particularly heavy in Africa and other parts of the developing world. A number of OHAM activities are conducting research to address this global problem:
OHAM International Activities
Advice on HIV/AIDS malignancy research is provided to the NCI and OHAM by the AIDS Malignancy Working Group, a dynamic, multidisciplinary group comprised of outside investigators, intramural and extramural NCI investigators, and community representatives:
AIDS Malignancy Working Group
HIV/AIDS and HIV malignancy research is conducted in many of the Divisions and Offices throughout the NCI. Click here to learn more about the broad spectrum of NCI HIV/AIDS research.
